Save your place

Sign in to WhoBought

Please try again later.

Invesco's Ionis Pharmaceuticals, Inc. (IONS) position

Yes: as of Q1 2026, Invesco holds 1.3M shares of IONS worth $96M (0.0% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$96M
Shares held
1.3M
% of portfolio
0.0%
Est. average buy price (i)
$64.56
est. since Q3 2025
Quarter-end price
$75.09

Estimated trade prices

Average price in quarters with purchases
$55.06
Average prices in quarters with sales
  • Q2 2025: $32.73 (619K shares sold)
  • Q4 2024: $37.38 (22K shares sold)
  • Q3 2024: $46.53 (159K shares sold)
  • Q2 2023: $38.43 (186K shares sold)
  • Q1 2023: $37.55 (7K shares sold)
  • Q3 2022: $42.14 (31K shares sold)
  • Q4 2021: $31.48 (9K shares sold)
  • Q3 2021: $37.68 (199K shares sold)
  • Q2 2021: $39.17 (2.0M shares sold)

IONS price vs Invesco's position

1Y 3Y 5Y MAX
Dates
$20$50$10020222023202420252026Sold 199K shares (58.5%) · Q3 2021. Average closing price $37.68 · Price range $33.54–$40.55199KsharessoldSold 9K shares (6.4%) · Q4 2021. Average closing price $31.48 · Price range $25.61–$35.109KsharessoldAdded 8K shares (5.9%) · Q1 2022. Average closing price $32.73 · Price range $29.88–$37.048KsharespurchasedAdded 186K shares (132.9%) · Q2 2022. Average closing price $37.71 · Price range $31.71–$43.00186KsharespurchasedSold 31K shares (9.4%) · Q3 2022. Average closing price $42.14 · Price range $36.54–$48.6631KsharessoldAdded 27K shares (9.2%) · Q4 2022. Average closing price $42.06 · Price range $37.12–$46.5227KsharespurchasedSold 7K shares (2.1%) · Q1 2023. Average closing price $37.55 · Price range $33.58–$41.207KsharessoldSold 186K shares (58.9%) · Q2 2023. Average closing price $38.43 · Price range $34.73–$43.33186KsharessoldAdded 1K shares (1.1%) · Q3 2023. Average closing price $41.26 · Price range $38.50–$47.131KsharespurchasedAdded 75K shares (57.0%) · Q4 2023. Average closing price $47.90 · Price range $43.39–$51.6375KsharespurchasedAdded 237K shares (115.1%) · Q1 2024. Average closing price $47.67 · Price range $42.03–$53.55237KsharespurchasedAdded 526K shares (118.8%) · Q2 2024. Average closing price $41.01 · Price range $36.45–$47.70526KsharespurchasedSold 159K shares (16.4%) · Q3 2024. Average closing price $46.53 · Price range $40.06–$51.86159KsharessoldSold 22K shares (2.7%) · Q4 2024. Average closing price $37.38 · Price range $33.73–$40.3622KsharessoldAdded 86K shares (10.9%) · Q1 2025. Average closing price $32.75 · Price range $30.17–$34.9786KsharespurchasedSold 619K shares (70.7%) · Q2 2025. Average closing price $32.73 · Price range $25.51–$40.00619KsharessoldAdded 750K shares (144.5%) · Q4 2025. Average closing price $75.30 · Price range $65.80–$82.73750KsharespurchasedAdded 8K shares (0.6%) · Q1 2026. Average closing price $78.92 · Price range $69.68–$86.508Ksharespurchased← Earlier —1 sell
Average closing price · filing quarter
$78.92
Price range · filing quarter
$69.68 – $86.50
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +8K +$637K +0.6% 1.3M May 12, 2026
Q4 2025 Added +750K +$56M +144.5% 1.3M Feb 19, 2026
Q3 2025 First covered – – – 519K Nov 13, 2025
Q2 2025 Reduced −619K −$20M −70.7% 256K Aug 13, 2025
Q1 2025 Added +86K +$2.8M +10.9% 875K May 12, 2025
Q4 2024 Reduced −22K −$811K −2.7% 789K Feb 13, 2025
Q3 2024 Reduced −159K −$7.4M −16.4% 810K Nov 12, 2024
Q2 2024 Added +526K +$22M +118.8% 969K Aug 13, 2024
Q1 2024 Added +237K +$11M +115.1% 443K May 14, 2024
Q4 2023 Added +75K +$3.6M +57.0% 206K Feb 13, 2024
Q3 2023 Added +1K +$60K +1.1% 131K Nov 13, 2023
Q2 2023 Reduced −186K −$7.1M −58.9% 130K Aug 11, 2023
Q1 2023 Reduced −7K −$253K −2.1% 316K May 12, 2023
Q4 2022 Added +27K +$1.1M +9.2% 322K Feb 13, 2023
Q3 2022 Reduced −31K −$1.3M −9.4% 295K Nov 14, 2022
Q2 2022 Added +186K +$7.0M +132.9% 326K Aug 15, 2022
Q1 2022 Added +8K +$254K +5.9% 140K May 16, 2022
Q4 2021 Reduced −9K −$287K −6.4% 132K Feb 14, 2022
Q3 2021 Reduced −199K −$7.5M −58.5% 141K Nov 15, 2021
Q2 2021 Reduced −2.0M −$79M −85.6% 341K Aug 17, 2021
Q1 2021 First covered – – – 2.4M May 17, 2021
Data through Q1 2026 · filed May 12, 2026
21 grouped rows from 21 quarters

More Invesco positions

NVIDIA Corporation(NVDA)
$24.7B
3.8% of portfolio

Apple Inc.(AAPL)
$18.4B
2.8% of portfolio

Microsoft Corporation(MSFT)
$15.7B
2.4% of portfolio

Alphabet Inc.(GOOGL)
$12.9B
2.0% of portfolio

Amazon.com, Inc.(AMZN)
$11.8B
1.8% of portfolio

Broadcom Inc.(AVGO)
$10.3B
1.6% of portfolio

Common questions

Does Invesco own IONS?

Yes. As of Q1 2026, Invesco disclosed 1.3M shares of IONS, worth $96M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy IONS?

Invesco held IONS since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell IONS?

The quarter-by-quarter table above shows each sale and reduction Invesco disclosed in IONS. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of IONS does Invesco own?

Invesco disclosed 1.3M shares of IONS as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for IONS?

Invesco began building the IONS position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.